Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27551018 | 0.86 | SLC5A2 (0.45) | SLC5A2SLC5A1 | |
| SCHEMBL27574260 | 0.84 | SLC5A2 (0.43) | SLC5A2SLC5A1 | |
| SCHEMBL7681079 | 0.81 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL6130178 | 0.80 | SLC5A2 (0.45) | SLC5A2SLC5A1 | |
| SCHEMBL29844391 | 0.80 | SLC5A2 (0.45) | SLC5A2SLC5A1 | |
| SCHEMBL28774531 | 0.78 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL7199793 | 0.78 | ACHE (0.44) | SLC5A2SLC5A1 | |
| SCHEMBL7122921 | 0.77 | SLC5A2 (0.43) | SLC5A2SLC5A1 | |
| SCHEMBL7195925 | 0.77 | SLC5A2 (0.37) | SLC5A2SLC5A1 | |
| SCHEMBL15814653 | 0.77 | SLC5A2 (0.43) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9421266-B2 | Safety of pseudoephedrine drug products | PISGAH LABORATORIES, INC. (US) | 2016-08-23 | — | — | US | claimed |
| US-20140178480-A1 | SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS | PISGAH LABORATORIES, INC. | 2014-06-26 | — | — | US | claimed |
| CN-110305414-B | Polyolefin composition and process for preparing the same | 赣州蓝风科技有限公司 | 2021-11-26 | — | — | CN | disclosed |
| US-9421266-B2 | Safety of pseudoephedrine drug products | PISGAH LABORATORIES, INC. (US) | 2016-08-23 | — | — | US | disclosed |
| US-20140178480-A1 | SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS | PISGAH LABORATORIES, INC. | 2014-06-26 | — | — | US | disclosed |
| CN-1303076-C | Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same | MILLIKEN & CO (US) | 2007-03-07 | — | — | CN | disclosed |
| CN-1293079-C | Process for preparing alditol acetals in high yields using mineral acids and surfactants | MILLIKEN & CO (US) | 2007-01-03 | — | — | CN | disclosed |
| CN-1511160-A | Process for preparing alditol acetals in high yields using mineral acids and surfactants | 美利肯公司 | 2004-07-07 | — | — | CN | disclosed |
| US-20020137953-A1 | Method of producing high yield alditol acetals with mineral acids and surfactants | MILLIKEN & COMPANY | 2002-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140178480-A1 | SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS | SORD, ABCB11, ABCB1 | SLC5A2 138/4885SLC5A1 75/4885 |
| US-20020137953-A1 | Method of producing high yield alditol acetals with mineral acids and surfactants | SORD, ALDOA, DERA | SLC5A2 176/4885SLC5A1 371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.